indazoles has been researched along with Cancer of Nose in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Drabick, JJ; Mackley, HB; Spengler, M; Wheelden, M | 1 |
Abarzúa, Á; Giesen, L; González, S; Molgó, M | 1 |
Arai, Y; Asano, T; Isono, M; Ito, K; Koga, A; Masunaga, A; Shinchi, Y; Tachi, K | 1 |
3 other study(ies) available for indazoles and Cancer of Nose
Article | Year |
---|---|
Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation.
Topics: Aged; Esthesioneuroblastoma, Olfactory; Female; Fumarate Hydratase; Humans; Indazoles; Mutation; Nasal Cavity; Neoplasm Recurrence, Local; Nose Neoplasms; Pyrimidines; Remission Induction; Retreatment; Sulfonamides; Time Factors | 2021 |
Nasal tumoral lesion: challenge. Cutaneous metastasis of renal cell carcinoma.
Topics: Aged; Angiogenesis Inhibitors; Biomarkers, Tumor; Biopsy; Carcinoma, Renal Cell; Fatal Outcome; Humans; Immunohistochemistry; Indazoles; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Nose Neoplasms; Pyrimidines; Skin Neoplasms; Sulfonamides; Time Factors; Treatment Outcome | 2015 |
[Metastatic Renal Cell Carcinoma in Paranasal Sinus for which Periodic Drug Withdrawal Schedule of Axitinib was Effective : A Case Report].
Topics: Axitinib; Carcinoma, Renal Cell; Imidazoles; Indazoles; Kidney Neoplasms; Nephrectomy; Nose Neoplasms; Protein Kinase Inhibitors; Tomography, X-Ray Computed; Treatment Outcome | 2016 |